TC
PODD icon

Trilogy Capital’s Insulet PODD Stock Holding History

Trilogy Capital’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,820
Closed -$2.9M – 420
2026
Q1 		$2.9M Buy
13,820
+1,363
+11% +$343K 0.13% 128
2025
Q4 		$3.54M Buy
12,457
+3,136
+34% +$981K 0.16% 105
2025
Q3 		$2.88M Buy
9,321
+1,350
+17% +$423K 0.13% 115
2025
Q2 		$2.5M Sell
7,971
-34
-0.4% -$9.81K 0.12% 132
2025
Q1 		$2.1M Buy
8,005
+252
+3% +$68.2K 0.11% 131
2024
Q4 		$2.02M Buy
+7,753
New +$1.95M 0.1% 142

Other funds holding PODD

ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
BIAS
Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
P
PensionDanmark Copenhagen O, Denmark $12B AUM
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
LTAS
Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Trilogy Capital's PODD Position: Q2 2026 in Review

Trilogy Capital sold out of Insulet (PODD) in Q2 2026, closing a stake of 13,820 shares — an estimated $2.9M sold.

Trilogy Capital first reported a position in PODD in Q4 2024 and held it in 6 quarters. The position peaked at $3.54M in Q4 2025. 77 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Trilogy Capital reported no remaining Insulet position as of Q2 2026 after selling out during the quarter.
  • Trilogy Capital sold 13,820 Insulet shares in Q2 2026, an estimated $2.9M.
  • Trilogy Capital first reported a position in Insulet in Q4 2024 and held it in 6 quarters.
  • Trilogy Capital's Insulet position peaked at $3.54M in Q4 2025.
  • 77 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.